SC-22716

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameSC-22716
Drug Alias NameSC-22716
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLeukotriene A-4 hydrolase inhibitors
TargetsLeukotriene A-4 hydrolase
Therapy Area/IndicationsPsoriasisInflammatory Bowel Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSearle
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSearle
Active IndicationsN/A
Inactive IndicationsPsoriasisInflammatory Bowel Diseases

Other Information

ATC CodeN/A
Related LinksN/A